NM_130468.4:c.43G>C

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_130468.4(CHST14):​c.43G>C​(p.Ala15Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000658 in 151,918 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A15S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

CHST14
NM_130468.4 missense

Scores

2
1
16

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 0.104

Publications

0 publications found
Variant links:
Genes affected
CHST14 (HGNC:24464): (carbohydrate sulfotransferase 14) This gene encodes a member of the HNK-1 family of sulfotransferases. The encoded protein transfers sulfate to the C-4 hydroxyl of N-acetylgalactosamine residues in dermatan sulfate. Mutations in this gene have been associated with adducted thumb-clubfoot syndrome.[provided by RefSeq, Mar 2010]
CHST14 Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome, musculocontractural type 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Ehlers-Danlos syndrome, musculocontractural type
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.12150967).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHST14NM_130468.4 linkc.43G>C p.Ala15Pro missense_variant Exon 1 of 1 ENST00000306243.7 NP_569735.1 Q8NCH0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHST14ENST00000306243.7 linkc.43G>C p.Ala15Pro missense_variant Exon 1 of 1 6 NM_130468.4 ENSP00000307297.6 Q8NCH0
CHST14ENST00000559991.1 linkc.43G>C p.Ala15Pro missense_variant Exon 1 of 2 5 ENSP00000453882.1 H0YN65
ENSG00000302612ENST00000788112.1 linkn.151+399C>G intron_variant Intron 1 of 4

Frequencies

GnomAD3 genomes
AF:
0.00000658
AC:
1
AN:
151918
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
1313158
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
646812
African (AFR)
AF:
0.00
AC:
0
AN:
25742
American (AMR)
AF:
0.00
AC:
0
AN:
23194
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
21758
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30432
South Asian (SAS)
AF:
0.00
AC:
0
AN:
70278
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
33308
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3880
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1050206
Other (OTH)
AF:
0.00
AC:
0
AN:
54360
GnomAD4 genome
AF:
0.00000658
AC:
1
AN:
151918
Hom.:
0
Cov.:
32
AF XY:
0.0000135
AC XY:
1
AN XY:
74202
show subpopulations
African (AFR)
AF:
0.0000242
AC:
1
AN:
41402
American (AMR)
AF:
0.00
AC:
0
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5158
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4836
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10552
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67912
Other (OTH)
AF:
0.00
AC:
0
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Ehlers-Danlos syndrome, musculocontractural type Uncertain:1
Mar 22, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The proline amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with CHST14-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the ExAC database. This sequence change replaces alanine with proline at codon 15 of the CHST14 protein (p.Ala15Pro). The alanine residue is moderately conserved and there is a small physicochemical difference between alanine and proline. -

Cardiovascular phenotype Uncertain:1
Sep 18, 2020
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.A15P variant (also known as c.43G>C), located in coding exon 1 of the CHST14 gene, results from a G to C substitution at nucleotide position 43. The alanine at codon 15 is replaced by proline, an amino acid with highly similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.062
BayesDel_addAF
Benign
-0.077
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.016
T;.
Eigen
Benign
-0.36
Eigen_PC
Benign
-0.20
FATHMM_MKL
Benign
0.68
D
LIST_S2
Benign
0.51
T;T
M_CAP
Pathogenic
0.50
D
MetaRNN
Benign
0.12
T;T
MetaSVM
Benign
-0.83
T
MutationAssessor
Benign
0.0
N;.
PhyloP100
0.10
PrimateAI
Pathogenic
0.87
D
PROVEAN
Benign
-0.44
N;N
REVEL
Benign
0.16
Sift
Benign
0.15
T;T
Sift4G
Benign
0.30
T;T
Polyphen
0.0010
B;.
Vest4
0.15
MutPred
0.12
Gain of catalytic residue at A15 (P = 0.0335);Gain of catalytic residue at A15 (P = 0.0335);
MVP
0.27
MPC
1.2
ClinPred
0.10
T
GERP RS
2.8
PromoterAI
-0.33
Neutral
Varity_R
0.12
gMVP
0.37

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1235160320; hg19: chr15-40763455; API